BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

376 related articles for article (PubMed ID: 11716809)

  • 1. Advanced glycation endproducts co-localize with inducible nitric oxide synthase in Alzheimer's disease.
    Wong A; Lüth HJ; Deuther-Conrad W; Dukic-Stefanovic S; Gasic-Milenkovic J; Arendt T; Münch G
    Brain Res; 2001 Nov; 920(1-2):32-40. PubMed ID: 11716809
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anti-inflammatory antioxidants attenuate the expression of inducible nitric oxide synthase mediated by advanced glycation endproducts in murine microglia.
    Wong A; Dukic-Stefanovic S; Gasic-Milenkovic J; Schinzel R; Wiesinger H; Riederer P; Münch G
    Eur J Neurosci; 2001 Dec; 14(12):1961-7. PubMed ID: 11860491
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of endothelial and inducible NOS-isoforms is increased in Alzheimer's disease, in APP23 transgenic mice and after experimental brain lesion in rat: evidence for an induction by amyloid pathology.
    Lüth HJ; Holzer M; Gärtner U; Staufenbiel M; Arendt T
    Brain Res; 2001 Sep; 913(1):57-67. PubMed ID: 11532247
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inducible nitric oxide synthase and argininosuccinate synthetase: co-induction in brain tissue of patients with Alzheimer's dementia and following stimulation with beta-amyloid 1-42 in vitro.
    Haas J; Storch-Hagenlocher B; Biessmann A; Wildemann B
    Neurosci Lett; 2002 Apr; 322(2):121-5. PubMed ID: 11958858
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neuronal and glial coexpression of argininosuccinate synthetase and inducible nitric oxide synthase in Alzheimer disease.
    Heneka MT; Wiesinger H; Dumitrescu-Ozimek L; Riederer P; Feinstein DL; Klockgether T
    J Neuropathol Exp Neurol; 2001 Sep; 60(9):906-16. PubMed ID: 11556547
    [TBL] [Abstract][Full Text] [Related]  

  • 6. beta-Amyloid stimulation of microglia and monocytes results in TNFalpha-dependent expression of inducible nitric oxide synthase and neuronal apoptosis.
    Combs CK; Karlo JC; Kao SC; Landreth GE
    J Neurosci; 2001 Feb; 21(4):1179-88. PubMed ID: 11160388
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preventing activation of receptor for advanced glycation endproducts in Alzheimer's disease.
    Lue LF; Yan SD; Stern DM; Walker DG
    Curr Drug Targets CNS Neurol Disord; 2005 Jun; 4(3):249-66. PubMed ID: 15975028
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Advanced glycation endproducts and pro-inflammatory cytokines in transgenic Tg2576 mice with amyloid plaque pathology.
    Münch G; Apelt J; Rosemarie-Kientsch-Engel ; Stahl P; Lüth HJ; Schliebs R
    J Neurochem; 2003 Jul; 86(2):283-9. PubMed ID: 12871569
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Amyloid-beta peptide activates cultured astrocytes: morphological alterations, cytokine induction and nitric oxide release.
    Hu J; Akama KT; Krafft GA; Chromy BA; Van Eldik LJ
    Brain Res; 1998 Mar; 785(2):195-206. PubMed ID: 9518610
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunohistochemical study of the expression of cytokines and nitric oxide synthases in brains of patients with dementia with Lewy bodies.
    Katsuse O; Iseki E; Kosaka K
    Neuropathology; 2003 Mar; 23(1):9-15. PubMed ID: 12722921
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Amyloid beta-peptide stimulates nitric oxide production in astrocytes through an NFkappaB-dependent mechanism.
    Akama KT; Albanese C; Pestell RG; Van Eldik LJ
    Proc Natl Acad Sci U S A; 1998 May; 95(10):5795-800. PubMed ID: 9576964
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inducible nitric oxide synthase immunoreactivity in the Alzheimer disease hippocampus: association with Hirano bodies, neurofibrillary tangles, and senile plaques.
    Lee SC; Zhao ML; Hirano A; Dickson DW
    J Neuropathol Exp Neurol; 1999 Nov; 58(11):1163-9. PubMed ID: 10560659
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Beta-amyloid peptide potentiates inflammatory responses induced by lipopolysaccharide, interferon -gamma and 'advanced glycation endproducts' in a murine microglia cell line.
    Gasic-Milenkovic J; Dukic-Stefanovic S; Deuther-Conrad W; Gärtner U; Münch G
    Eur J Neurosci; 2003 Feb; 17(4):813-21. PubMed ID: 12603271
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Advanced glycation end products are mitogenic signals and trigger cell cycle reentry of neurons in Alzheimer's disease brain.
    Kuhla A; Ludwig SC; Kuhla B; Münch G; Vollmar B
    Neurobiol Aging; 2015 Feb; 36(2):753-61. PubMed ID: 25448604
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of lysosomal proteins Progranulin and Prosaposin and their interactions in Alzheimer's disease and aged brains: increased levels correlate with neuropathology.
    Mendsaikhan A; Tooyama I; Bellier JP; Serrano GE; Sue LI; Lue LF; Beach TG; Walker DG
    Acta Neuropathol Commun; 2019 Dec; 7(1):215. PubMed ID: 31864418
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fibrillary beta-amyloid deposits are closely associated with atrophic nitric oxide synthase (NOS)-expressing neurons but do not upregulate the inducible NOS in transgenic Tg2576 mouse brain with Alzheimer pathology.
    Hartlage-Rübsamen M; Apelt J; Schliebs R
    Neurosci Lett; 2001 Apr; 302(2-3):73-6. PubMed ID: 11290390
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Advanced glycation endproducts and their receptor RAGE in Alzheimer's disease.
    Srikanth V; Maczurek A; Phan T; Steele M; Westcott B; Juskiw D; Münch G
    Neurobiol Aging; 2011 May; 32(5):763-77. PubMed ID: 19464758
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Distinct inflammatory phenotypes of microglia and monocyte-derived macrophages in Alzheimer's disease models: effects of aging and amyloid pathology.
    Martin E; Boucher C; Fontaine B; Delarasse C
    Aging Cell; 2017 Feb; 16(1):27-38. PubMed ID: 27723233
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chronic hyperglycemia induced via the heterozygous knockout of Pdx1 worsens neuropathological lesion in an Alzheimer mouse model.
    Guo C; Zhang S; Li JY; Ding C; Yang ZH; Chai R; Wang X; Wang ZY
    Sci Rep; 2016 Jul; 6():29396. PubMed ID: 27406855
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunohistochemical distribution of the receptor for advanced glycation end products in neurons and astrocytes in Alzheimer's disease.
    Sasaki N; Toki S; Chowei H; Saito T; Nakano N; Hayashi Y; Takeuchi M; Makita Z
    Brain Res; 2001 Jan; 888(2):256-262. PubMed ID: 11150482
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.